Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 485
Results: 10
B cell lymphoma R-CHOPped by metabolic inhibitors.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aax3456
- By:
- Publication type:
- Article
Erratum for the Research Article: "Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis" by D. A. Rosen, S. M. Seki, A. Fernández-Castañeda, R. M. Beiter, J. D. Eccles, J. A. Woodfolk, A. Gaultier
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aax3130
- Publication type:
- Article
Prevention of cystic fibrosis: The beginning of the end?
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aax2361
- By:
- Publication type:
- Article
Blood drive: Improving the yields of platelet cell manufacturing.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aax1718
- By:
- Publication type:
- Article
Teaching an old antibody response new tricks.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aax1716
- By:
- Publication type:
- Article
A pannexin 1 channelopathy causes human oocyte death.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aav8731
- By:
- Publication type:
- Article
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aau7746
- By:
- Publication type:
- Article
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aau7531
- By:
- Publication type:
- Article
Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aau6934
- By:
- Publication type:
- Article
A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 485, p. N.PAG, doi. 10.1126/scitranslmed.aat3005
- By:
- Publication type:
- Article